Mel

Meloxicam, the active ingredient in Mel, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for systemic use. It reduces inflammation and pain associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal pain in adult patients.

GNH USA supplies Mel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and provides regulatory documentation for each batch. Its global distribution network ensures timely delivery to diverse healthcare settings, supporting patient care across multiple regions.

Meloxicam is indicated for several inflammatory and degenerative joint conditions where COX‑2 mediated prostaglandin production contributes to pain and swelling. - Osteoarthritis: reduces joint pain and improves functional mobility in patients with degenerative cartilage loss. - Rheumatoid arthritis: alleviates inflammatory joint pain and stiffness in autoimmune synovitis. - Ankylosing spondylitis: diminishes spinal inflammation and associated chronic back pain. - Acute pain: provides short‑term relief of moderate to severe musculoskeletal pain.

Meloxicam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dyspepsia or nausea. - Headache. - Dizziness. - Mild skin rash.

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding. - Cardiovascular events such as heart attack or stroke. - Liver enzyme elevation or hepatitis. - Severe renal impairment or anaphylaxis.

When prescribing meloxicam, clinicians should evaluate patient risk factors and monitor for potential complications. - Assess gastrointestinal risk: avoid in patients with active ulcers or a history of GI bleeding. - Monitor blood pressure: NSAIDs can raise systolic and diastolic values. - Evaluate renal function: use caution in patients with impaired kidney function. - Review hepatic status: periodic liver enzyme testing is advisable. - Avoid concomitant use with other NSAIDs or COX‑2 inhibitors unless medically justified. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Meloxicam can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk. - Lithium: increased serum lithium levels. - Methotrexate: amplified toxicity risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible renal function changes. - Diuretics: may affect blood pressure control. - SSRIs or SNRIs: modest increase in bleeding tendency.